Stein Steven H's Form 4 filing
Incyte Corp (INCY) · filed Jan 22, 2025
- Accession no.
- 0000879169-25-000032
- Filed
- Jan 22, 2025
- Trade date
- Jan 17-21, 2025
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market sales total $897.9K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Stein Steven HCIK 0001673776 | Officer (EVP & Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 21, 2025 | Common Stock | SSaleDisposed | −12,352 | $72.69 | −$897,866.88 | 66,967 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 17, 2025 | Common Stock | AGrant or awardAcquired | +28,202 | $0.00 | $0 | 28,202 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.